Stockholm, October 30th, 2015
Karin Bernadotte, board member and primary insider in ContextVision AB, has on October 29th 2015 purchased 3 000 shares in ContextVision AB at a price of NOK 22,18 per share. Following this transaction, Karin Bernadotte owns 3 000 shares in ContextVision AB.
For inquires please contact CEO Anita Tollstadius; firstname.lastname@example.org
This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act.
ContextVision’s cutting-edge technology helps doctors more accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, the company’s state-of-the-art medical image analysis and enhancement software for 2D/3D/4D Ultrasound, MRI, X-Ray and Mammography is used by leading equipment manufacturers worldwide. ContextVision continues to invest heavily in R&D in order to expand its technology platform. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com.